Skip to content
Screener

Alto Neuroscience ANRO Other Research And Development Expense

Other Research And Development Expense at other companies

Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$1.98M-36.4%
OS Therapies logo
OS TherapiesOSTX
$0—
RFL
Rafael Holdings, Inc.RFL
$22K-51.1%
CTO
Citius Oncology, Inc.CTOR
$469K-2.3%
TG Therapeutics logo
TG TherapeuticsTGTX
$87.27M+218%
TG Therapeutics logo
TG TherapeuticsTGTX
$87.27M+218%

Segments

By segment

See full
Reportable segment$1.2M+6.1%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$1.11B+1,245%
Enterprise value$871.03M-2,281%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×